logo
Uttar Pradesh: Forest and Wildlife Department launches plan to preserve natural habitats of Rhinos and other endangered wildlife species

Uttar Pradesh: Forest and Wildlife Department launches plan to preserve natural habitats of Rhinos and other endangered wildlife species

India Gazette19-06-2025
Lucknow (Uttar Pradesh) [India], June 19 (ANI): Under the guidance of Chief Minister Yogi Adityanath, the Forest and Wildlife Department of Uttar Pradesh has launched an ambitious plan aimed at preserving the natural habitats of rhinos and other endangered wildlife species, as per a release.
As part of this initiative, two new Rhino Rehabilitation Centres (RRCs) will be developed in the Dudhwa National Park located in Lakhimpur. A total of Rs 1.5 crore has been allocated for this project.
The funds will be used for long-term habitat conservation, staff training, procurement of medicines and equipment, and community awareness efforts regarding wildlife protection.
Additionally, the Forest and Wildlife Department has undertaken a comprehensive conservation project in the Terai region of Uttar Pradesh with a focus on the long-term preservation of natural habitats for rhinos and other threatened wildlife.
This project will be implemented specifically in Dudhwa National Park. The primary goal is to ensure sustainable measures for the protection of rhinos' natural habitats. According to Deputy Director of Dudhwa National Park, Rangaraju, Rs 1.5 crore has been sanctioned for the creation of two new natural enclosures - Rhino Rehabilitation Centres - within the park for the protection of rhinos and other endangered species.
Previously, RRC-1 and RRC-2 were established in the national park. The upcoming centres, RRC-3 and RRC-4, will be modelled similarly and will provide open forest space under special monitoring to allow rhinos to thrive in a natural environment while maintaining their instinctive behaviours.
These centres will also contribute to the conservation of other endangered species in the region.
The Deputy Director stated that the allocated funds will be utilised across various conservation activities. Out of the total, Rs 1.27 crore will be used for maintaining the rhinos' natural habitat, including water bodies, suitable vegetation, and area upkeep.
Approximately Rs 7 lakh has been earmarked for medicines and chemicals for wildlife, Rs 4.8 lakh for major construction activities, and Rs 3 lakh for minor infrastructure development.
An additional Rs 7 lakh will be spent on monitoring equipment, machines, and necessary installations.
The project also aims to strengthen anti-poaching surveillance and curb the illegal trade of rhino body parts. To achieve this, training programs will be organized to engage and educate the local communities about wildlife conservation.
The Yogi government's initiative is expected to not only boost the population of rhinos in the state but also enhance the overall biodiversity of the Dudhwa region. (ANI)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AstraZeneca Pharma India's net profit slips 4 pc in Q1
AstraZeneca Pharma India's net profit slips 4 pc in Q1

Hans India

timean hour ago

  • Hans India

AstraZeneca Pharma India's net profit slips 4 pc in Q1

Mumbai: AstraZeneca Pharma India Limited on Thursday reported a 4.12 per cent decline in net profit for the first quarter (Q1) of FY26, with earnings falling to Rs 55.8 crore from Rs 58.2 crore in the previous quarter (Q4 FY25). This dip came despite a strong rise in revenue from operations, which grew 9.56 per cent sequentially to Rs 526.3 crore from Rs 480.4 crore, according to its stock exchange filing. Other income saw a sharp decline of 30.43 per cent, dropping to Rs 11.2 crore from Rs 16.1 crore in Q4 FY25. However, total income rose 8.23 per cent to Rs 537.5 crore from Rs 496.6 crore, driven by solid operational performance. Total expenses increased by 12.12 per cent to Rs 462.4 crore, compared to Rs 412.4 crore in the previous quarter, the company stated in its regulatory filing. Bhavana Agrawal, Chief Financial Officer and Director of the Company, said the strong quarterly performance reflects the power of science-led innovation combined with disciplined execution. 'Each regulatory milestone brings us closer to transforming outcomes for patients living with chronic diseases. We remain focused on expanding our portfolio, strengthening partnerships, and ensuring that breakthrough medicines reach the people who need them most,' she added. Praveen Rao Akkinepally, Country President and Managing Director, said that delivering consistent growth across therapy areas reaffirms the strength of the company's 'Growth Through Innovation' strategy. 'These results are a testament to what is possible when science and purpose come together,' he noted. AstraZeneca, a global science-led biopharmaceutical company, focuses on the discovery, development, and commercialisation of prescription medicines, primarily in oncology, cardiovascular, renal and metabolism, respiratory, and rare diseases. The company operates in over 100 countries, with its medicines used by millions of patients worldwide. Completing 45 years in India, AstraZeneca Pharma India Limited is headquartered in Bengaluru and employs over 600 people across the country.

Cash On 'Delivery': This Country Is Paying Couples To Have Children; The Amount Will Blow Your Mind
Cash On 'Delivery': This Country Is Paying Couples To Have Children; The Amount Will Blow Your Mind

News18

time2 hours ago

  • News18

Cash On 'Delivery': This Country Is Paying Couples To Have Children; The Amount Will Blow Your Mind

The proposal, expected to secure cabinet approval soon, will extend the subsidy across multiple stages of IVF treatment, from the first attempt through the sixth In a bold move to counter its declining birth rate, Taiwan has announced a significant expansion of its financial support for couples seeking to have children through in-vitro fertilisation (IVF). The government will now offer up to Rs 6 lakh in assistance, more than double the current Rs 3 lakh, in an effort to make the costly procedure more accessible. The proposal, expected to secure cabinet approval soon, will extend the subsidy across multiple stages of IVF treatment, from the first attempt through the sixth. Until now, only the initial stage received such support. Officials said that the change addresses a key deterrent; IVF often requires several rounds to succeed, and many couples abandon the process due to escalating costs. Governments across the region are experimenting with incentives to boost birth rates. China, grappling with the long-term effects of its one-child policy, has introduced a national child-care subsidy starting January 2025 – 3,600 yuan (around Rs 43,000) annually for every child under three, with additional state-level benefits. Russia, facing a similar demographic crunch, offers Rs 6.65 lakh for a first child and Rs 8.70 lakh for a second. Some regions have gone further, extending payments even to schoolgirls who become pregnant. For Taiwan, officials hope that easing the financial burden of IVF will help reverse a trend that, if left unchecked, could reshape the nation's economy and workforce in the decades ahead. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Top 10 Nursing Colleges In India: Courses, Admissions, Duration
Top 10 Nursing Colleges In India: Courses, Admissions, Duration

NDTV

time3 hours ago

  • NDTV

Top 10 Nursing Colleges In India: Courses, Admissions, Duration

Pursuing a Bachelor of Science (BSc) in Nursing from a reputed institution is a crucial step for those aiming to build a successful career in healthcare. India's leading nursing colleges are known for combining strong academic training with extensive clinical exposure, research opportunities, and skill development. As per the latest rankings, the top institutes offering BSc Nursing include AIIMS Delhi, PGIMER Chandigarh, Christian Medical College (Vellore), National Institute of Mental Health and Neuro Sciences (Bengaluru), Jawaharlal Institute of Postgraduate Medical Education and Research (Puducherry), Sanjay Gandhi Postgraduate Institute of Medical Sciences, Banaras Hindu University, Amrita Vishwa Vidyapeetham, Kasturba Medical College (Manipal), and Madras Medical College. Admissions and Eligibility Candidates must have completed Class 12 with at least 55% in Physics, Chemistry, and Biology from a recognised board. Admissions are based on either Class 12 merit or entrance exams such as KCET, AP EAMCET, JENPAS UG, TS EAMCET, NEET, or CUET. While NEET is not mandatory, some institutions use it for shortlisting. Programme Highlights AIIMS Delhi: Four-year BSc Nursing with 77 seats; NEET-based admission; tuition fee Rs 600. Offers specialisations including Pediatric, Psychiatric, and Critical Care Nursing. PGIMER Chandigarh: Offers BSc and Post-Basic BSc Nursing; entrance exam in June; tuition fee Rs 1,000. CMC Vellore: Established in 1946; tuition fee Rs 810 per year; multiple nursing specialisations; scholarships available. NIMHANS Bengaluru: Focus on psychiatric and neurological nursing; total cost Rs 1.4 lakh. JIPMER Puducherry: NEET-based admission; 94 seats; mandatory 24-week paid internship; annual fee Rs 5,760. These institutions not only prepare students for roles in top hospitals but also equip them for higher studies and community healthcare roles, making them some of the most sought-after destinations for nursing education in India.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store